These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10393567)

  • 41. Using different experimental designs in drug-excipient compatibility studies during the preformulation development of a stable solid dosage formulation.
    Bohanec S; Peterka TR; Blažič P; Jurečič R; Grmaš J; Krivec A; Zakrajšek J
    Acta Chim Slov; 2010 Dec; 57(4):895-903. PubMed ID: 24061893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stability of pharmaceutical salts in solid oral dosage forms.
    Nie H; Byrn SR; Zhou QT
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1215-1228. PubMed ID: 28276282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The stress stability of olanzapine: studies of interactions with excipients in solid state pharmaceutical formulations.
    Djordjević Filijović N; Antonijević MD; Pavlović A; Vučković I; Nikolić K; Agbaba D
    Drug Dev Ind Pharm; 2015 Mar; 41(3):502-14. PubMed ID: 24611817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of mixture design in drug-excipient compatibility determinations: Thymol nanoparticles case study.
    Pires FQ; Angelo T; Silva JK; Sá-Barreto LC; Lima EM; Gelfuso GM; Gratieri T; Cunha-Filho MS
    J Pharm Biomed Anal; 2017 Apr; 137():196-203. PubMed ID: 28131059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biowaiver monographs for immediate release solid oral dosage forms: rifampicin.
    Becker C; Dressman JB; Junginger HE; Kopp S; Midha KK; Shah VP; Stavchansky S; Barends DM
    J Pharm Sci; 2009 Jul; 98(7):2252-67. PubMed ID: 19160441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Manipulation of Pharmaceutical Polymorphic Transformation Process Using Excipients.
    Tian B; Ding Z; Zong S; Yang J; Wang N; Wang T; Huang X; Hao H
    Curr Pharm Des; 2020; 26(21):2553-2563. PubMed ID: 32053064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of excipient molecular weight in drug release by fibrous dosage forms with close packing and high drug loading.
    Blaesi AH; Saka N
    Int J Pharm; 2021 Sep; 606():120009. PubMed ID: 33246051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate.
    Hugo M; Kunath K; Dressman J
    Drug Dev Ind Pharm; 2013 Feb; 39(2):402-12. PubMed ID: 22591213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of excipients on the crystallization of pharmaceutical compounds during lyophilization.
    Korey DJ; Schwartz JB
    J Parenter Sci Technol; 1989; 43(2):80-3. PubMed ID: 2709239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-excipient compatibility studies in binary mixtures of avobenzone.
    Ceresole R; Han YK; Rosasco MA; Orelli LR; Segall A
    J Cosmet Sci; 2013; 64(5):317-28. PubMed ID: 24139431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The stability of solid dispersions of felodipine in polyvinylpyrrolidone characterized by nanothermal analysis.
    Zhang J; Bunker M; Parker A; Madden-Smith CE; Patel N; Roberts CJ
    Int J Pharm; 2011 Jul; 414(1-2):210-7. PubMed ID: 21627985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement.
    Sanganwar GP; Sathigari S; Babu RJ; Gupta RB
    Eur J Pharm Sci; 2010 Jan; 39(1-3):164-74. PubMed ID: 19961931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA; Ji Q; Joshi YM; Serajuddin AT
    Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Solid-State Form on the Disproportionation of Miconazole Mesylate.
    Patel MA; Luthra S; Shamblin SL; Arora K; Krzyzaniak JF; Taylor LS
    Mol Pharm; 2018 Jan; 15(1):40-52. PubMed ID: 29202237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of amorphization method on telmisartan solubility and the tableting process.
    Lepek P; Sawicki W; Wlodarski K; Wojnarowska Z; Paluch M; Guzik L
    Eur J Pharm Biopharm; 2013 Jan; 83(1):114-21. PubMed ID: 23085331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding the physical stability of freeze dried dosage forms from the glass transition temperature of the amorphous components.
    Fitzpatrick S; Saklatvala R
    J Pharm Sci; 2003 Dec; 92(12):2495-501. PubMed ID: 14603495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A generalized relation for solid-state drug stability as a function of excipient dilution: temperature-independent behavior.
    Waterman KC; Gerst P; Dai Z
    J Pharm Sci; 2012 Nov; 101(11):4170-7. PubMed ID: 22847821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immediate drug release from solid oral dosage forms.
    Schreiner T; Schaefer UF; Loth H
    J Pharm Sci; 2005 Jan; 94(1):120-33. PubMed ID: 15761936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of HPLC to assess the compatibility of bisoprolol fumarate with selected excipients in mixtures by isothermal stress testing.
    Marothu VK; Yerramothu P; Gorrepati M; Majeti S; Mamidala SK; Nellutla A
    Ann Pharm Fr; 2015 Nov; 73(6):442-51. PubMed ID: 26142745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.